ISTI LOGO
Towards a new dawn
×

img Acces sibility Controls

Research Projects Banner

Research Projects

A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients

Implementing Organization

Translational Health Science & Technology Institute, Haryana
Principal Investigator
Ms. N. Wadhwa
Associate Professor
|
Translational Health Science & Technology Institute, Haryana

Related Research

View All
Funding Organization
Funding Organization

—

Quick Information
Area of Research
Medical Sciences
Focus Area
Task Force (TF)
Start Year
2019
End Year
2023
Sanction Amount
₹ 89.16 L
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop